Citations

Clear

9383 citation(s) found for "Thomas, PS".

Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer
Goode, Ellen L. , García‐Closas, Montserrat , Severi, Gianluca , Hein, Rebecca, Fredericksen, Zachary, Malats, Núria , Zamora, M. Pilar , Dörk, Thilo , Schürmann, Peter , Karstens, Johann H., Hillemanns, Peter , Cox, Angela , Brock, Ian W., Elliot, Graeme, Cross, Simon S. , Seal, Sheila, Turnbull, Clare , Renwick, Anthony, Rahman, Nazneen , Shen, Chen‐Yang , Yu, Jyh‐Cherng , Huang, Chiun‐Sheng , Hou, Ming‐Feng , Nordestgaard, Børge G. , Bojesen, Stig E. , Lanng, Charlotte, Alnæs, Grethe Grenaker, Kristensen, Vessela N. , Børrensen-Dale, Anne-Lise, Hopper, John L. , Dite, Gillian S. , Apicella, Carmel, Southey, Melissa C. , Lambrechts, Diether , Yesilyurt, Betül T., Floris, Giuseppe , Leunen, Karin, Sangrajrang, Suleeporn , Gaborieau, Valérie , McKay, James , Chang‐Claude, Jenny , Wang‐Gohrke, Shan , Radice, Paolo , Peterlongo, Paolo , Manoukian, Siranoush , Barile, Monica, Giles, Graham G. , Baglietto, Laura , John, Esther M. , Miron, Alexander, Lissowska, Jolanta , Sherman, Mark E., Bogdanova, Natalia , Antonenkova, Natalia, Zalutsky, Iosif V., Rogov, Yuriy , Fasching, Peter A. , Ekici, Arif B. , Beckmann, Matthias W. , Brenner, Hermann , Stegmaier, Christa, Andrulis, Irene L. , Knight, Julia A. , Glendon, Gord, Mulligan, Anna Marie , Mannermaa, Arto, Kataja, Vesa , Kosma, Veli‐Matti , Hartikainen, Jaana M. , Meindl, Alfons , Bartram, Claus R., Schmutzler, Rita K., Thomas, Gilles D., Hoover, Robert N. , Fletcher, Olivia , Gibson, Lorna J., dos‐Santos‐Silva, Isabel , Peto, Julian, Nickels, Stefan , Flesch‐Janys, Dieter, Sawyer, Elinor J. , Tomlinson, Ian , Kerin, Michael J. , Miller, Nicola, Schmidt, Marjanka K. , Veer, Laura van ‘t , Tollenaar, Rob A.�E.�M. , Dunning, Alison M. , Pooley, Karen A. , Schneeweiß, Andreas , Sohn, Christof , Burwinkel, Barbara , Jakubowska, Anna , Lubiński, Jan , Jaworska, Katarzyna, Durda, Katarzyna, Kang, Daehee , Noh, Dong‐Young , Ahn, Sei-Hyun, Hunter, David J. , Hankinson, Susan E. , Lindström, Sara, Chen, Xiaoqing, Beesley, Jonathan, Hamann, Ute, Justenhoven, Christina , Network, for the GENICA, Winqvist, Robert , Pylkäs, Katri , Jukkola‐Vuorinen, Arja , Grip, Mervi, Hooning, Maartje J. , Hollestelle, Antoinette , Oldenburg, Rogier A., Tilanus‐Linthorst, Madeleine M.A., Хуснутдинова, Э. К. , Bermisheva, Marina , Prokofieva, Darya, Farahtdinova, Albina, Humphreys, Manjeet K., Wang, Qin , Chenevix‐Trench, Georgia , Easton, Douglas F. , Lambrechts, Diether , Milne, Roger L. , Couch, Fergus J. , Pérez, José Ignacio Arias , Benı́tez, Javier , Børrensen-Dale, Anne-Lise, Brennan, Paul , Chanock, Stephen Jacob , Figueroa, Jonine D. , Bayer, Christian , Müller, Heiko , Arndt, Volker , Mannermaa, Arto, Meindl, Alfons , Heil, Joerg , Anton‐Culver, Hoda , Ziogas, Argyrios , Broeks, Annegien , Veer, Laura J. van’t , Pharoah, Paul D.P. , Marmé, Frederik , Yoo, Keun-Young , Hankinson, Susan E. , Kraft, Peter , Chen, Xiaoqing, Harth, Volker , Network, for the GENICA, Olson, Janet E. , Wang, Xianshu , Dörk, Thilo , Lambrechts, Diether , Giles, Graham G , Peterlongo, Paolo , Hillemanns, Peter , Radice, Paolo , Lissowska, Jolanta , John, Esther M , Southey, Melissa C , Malats, Nuria , Dunning, Alison M , Jakubowska, Anna , Lambrechts, Diether , Brenner, Hermann , Cox, Angela , García-Closas, Montserrat , Schmidt, Marjanka K , Severi, Gianluca , Ekici, Arif B , Hartikainen, Jaana M , Bogdanova, Natalia V , Chenevix-Trench, Georgia , Pylkäs, Katri , Manoukian, Siranoush , Lubinski, Jan , Baglietto, Laura , Fletcher, Olivia , Bojesen, Stig E , Huang, Chiun-Sheng , Sawyer, Elinor J , Kang, Daehee

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | October 6, 2011 | Volume: 20 | Issue: 10 | Pages: 2222-2231

10.1158/1055-9965.epi-11-0569 | PMID 21795498 Get It

Abstract Background: The single-nucleotide polymorphism (SNP) 5p12-rs10941679 has been found to be associated with risk of breast cancer, particularly estrogen receptor (ER)-positive disease. We aimed to further explore this association overall, and by tumor histopathology, in the Breast Cancer Association Consortium. Methods: Data were combined from 37 studies, including 40,972 invasive cases, 1,398 cases of ductal carcinoma in situ (DCIS), and 46,334 controls, all of white European ancestry, as well as 3,007 invasive cases and 2,337 controls of Asian ancestry. Associations overall and by tumor invasiveness and histopathology were assessed using logistic regression. Results: For white Europeans, the per-allele OR associated with 5p12-rs10941679 was 1.11 (95% CI = 1.08–1.14, P = 7 × 10−18) for invasive breast cancer and 1.10 (95% CI = 1.01–1.21, P = 0.03) for DCIS. For Asian women, the estimated OR for invasive disease was similar (OR = 1.07, 95%CI = 0.99–1.15, P = 0.09). Further analyses suggested that the association in white Europeans was largely limited to progesterone receptor (PR)-positive disease (per-allele OR = 1.16, 95% CI = 1.12–1.20, P = 1 × 10−18 vs. OR = 1.03, 95% CI = 0.99–1.07, P = 0.2 for PR-negative disease; Pheterogeneity = 2 × 10−7); heterogeneity by ER status was not observed (P = 0.2) once PR status was accounted for. The association was also stronger for lower grade tumors [per-allele OR (95% CI) = 1.20 (1.14–1.25), 1.13 (1.09–1.16), and 1.04 (0.99–1.08) for grade 1, 2, and 3/4, respectively; Ptrend = 5 × 10−7]. Conclusion: 5p12 is a breast cancer susceptibility locus for PR-positive, lower grade breast cancer. Impact: Multicenter fine-mapping studies of this region are needed as a first step to identifying the causal variant or variants. Cancer Epidemiol Biomarkers Prev; 20(10); 2222–31. ©2011 AACR.
Meralgia paresthetica
Parisi, Thomas J., Mandrekar, Jay , Dyck, Peter James , Klein, Christopher J. , Klein, Christopher J

Mayo Clinic

Neurology | October 5, 2011 | Volume: 77 | Issue: 16 | Pages: 1538-1542

10.1212/wnl.0b013e318233b356 | PMID 21975198 Get It

Using Simulation to Design and Improve an Outpatient Procedure Center
Huschka, Todd R., Rohleder, Thomas R., Denton, Brian T.

Mayo Clinic

Management Engineering for Effective Healthcare Delivery | October 4, 2011 | Volume: No volume available | Issue: No issue available | Pages: 216-228

10.4018/978-1-60960-872-9.ch010 Get It

Discrete-event simulation (DES) is an effective tool to for analyzing and improving healthcare processes. In this chapter we discuss the use of simulation to improve patient flow at an outpatient procedure center (OPC) at Mayo Clinic. The OPC addressed is the Pain Clinic, which was faced with high patient volumes in a new, untested facility. Simulation was particularly useful due to the uncertain patient procedure and recovery times. We discuss the simulation process and show how it helped reduce patient waiting time while ensuring the clinic could meet its target patient volumes.
Learning Curve of Robotic-Assisted Microvascular Anastomosis in the Rat
Mattar, Tiago Guedes da Motta , Parisi, Thomas J., Carlsen, Brian T. , Shin, Alexander Y. , Lee, Joo‐Yup , Bishop, Allen T. , Shin, Alexander Y

Mayo Clinic

Journal of Reconstructive Microsurgery | September 30, 2011 | Volume: 28 | Issue: 07 | Pages: 451-456

10.1055/s-0031-1289166 | PMID 21959547 Get It

A Multidisciplinary Evaluation of Inter-Reviewer Agreement of the Nephrometry Score and the Prediction of Long-Term Outcomes
Weight, Christopher , Atwell, Thomas D. , Fazzio, Robert T. , Kim, Simon P. , Kenny, McCabe C., Lohse, Christine M. , Boorjian, Stephen A. , Leibovich, Bradley C. , Thompson, R. Houston

Mayo Clinic

Journal of Urology | September 29, 2011 | Volume: 186 | Issue: 4 | Pages: 1223-1228

10.1016/j.juro.2011.05.052 | PMID 21849200 Get It

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine
Varon, SF, Grosberg, Brian M. , McAllister, Peter J., Freitag, F. G., Aurora, SK, Silberstein, Stephen D., DeGryse, Ronald E., Nolan, Marissa E., Turkel, Catherine C., Lipton, Richard B. , Dodick, David W. , Diener, Hans‐Christoph

Mayo Clinic

Neurology | September 29, 2011 | Volume: 77 | Issue: 15 | Pages: 1465-1472

10.1212/wnl.0b013e318232ab65 | PMID 21956721 Get It

Renal Function Outcomes in Patients Treated With Partial Nephrectomy Versus Percutaneous Ablation for Renal Tumors in a Solitary Kidney
Mitchell, Christopher , Atwell, Thomas D. , Weisbrod, Adam J. , Lohse, Christine M. , Boorjian, Stephen A. , Leibovich, Bradley C. , Thompson, R. Houston

Mayo Clinic

Journal of Urology | September 26, 2011 | Volume: 186 | Issue: 5 | Pages: 1786-1790

10.1016/j.juro.2011.07.036 | PMID 21944103 Get It

Rapid Detection of Coronary Artery Stenoses With Real-Time Perfusion Echocardiography During Regadenoson Stress
Porter, Thomas R. , Adolphson, Mary, High, Robin , Olson, Joan, Erdkamp, Michelle, Xie, Feng , O’Leary, Edward , Wong, Benjamin F., Eifert-Rain, Susan, Hagen, Mary E., Abdelmoneim, Sahar S. , Smith, Lynette M. , Mulvagh, Sharon L.

Mayo Clinic

Circulation: Cardiovascular Imaging | September 24, 2011 | Volume: 4 | Issue: 6 | Pages: 628-635

10.1161/circimaging.111.966341 | PMID 21946702 Get It

Background— Real-time myocardial contrast echocardiography permits the detection of myocardial perfusion abnormalities during stress echocardiography, which may improve the accuracy of the test in detecting coronary artery stenoses. We hypothesized that this technique could be used after a bolus injection of the selective A2A receptor agonist regadenoson to rapidly and safely detect coronary artery stenoses. Methods and Results— In 100 patients referred for quantitative coronary angiography, real-time myocardial contrast echocardiography was performed during a continuous intravenous infusion of 3% Definity at baseline and at 2-minute intervals for up to 6 minutes after a regadenoson bolus injection (400 μg). Myocardial perfusion was assessed by examination of myocardial contrast replenishment after brief high mechanical index impulses. A perfusion defect was defined as a delay (>2 seconds) in myocardial contrast replenishment in 2 contiguous segments. Wall motion was also analyzed. The overall sensitivity/specificity/accuracy for myocardial perfusion analysis in detecting a >50% diameter stenosis was 80%/74%/78%, whereas for wall motion analysis it was 60%/72%/66% ( P <0.001 for differences in sensitivity). Sensitivity for myocardial perfusion analysis was highest on images obtained during the first 2 minutes after regadenoson bolus ( P <0.001 compared with wall motion), whereas wall motion sensitivity was highest at the 4-to-6–minute period after the bolus. No significant side effects occurred after regadenoson bolus injection. Conclusions— Regadenoson real-time myocardial contrast echocardiography appears to be a feasible, safe, and rapid noninvasive method for the detection of significant coronary artery stenoses. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT0087369.
Rectal Injury During Robot-Assisted Radical Prostatectomy: Incidence and Management
Wedmid, Alexei, Mendoza, Pierre J., Sharma, Saurabh , Hastings, Rachel, Monahan, Kelly, Walicki, Mary, Ahlering, Thomas E. , Porter, James , Castle, Erik P., Engel, Jason D., Frazier, Harold A. , Lee, David I. , Ahmed, Faisal Awad , Eun, Daniel

Mayo Clinic

Journal of Urology | September 23, 2011 | Volume: 186 | Issue: 5 | Pages: 1928-1933

10.1016/j.juro.2011.07.004 | PMID 21944109 Get It

Siblings With Ischemic Stroke Study
Nalls, Michael A., Matarín, Mar, Brott, Thomas G. , Brown, Robert D. , Hardy, John , Kissela, Brett , Rich, Stephen S. , Singleton, Andrew , Hernandez, Dena G., Ferrucci, Luigi , Pearce, Kerra, Keller, M., Worrall, Bradford B. , Investigators*, for the Siblings With Ischemic Stroke Study, Burgin, W. Scott , Meschia, James F. , Investigators*, for the Siblings With Ischemic Stroke Study, Rich, Stephen S , Hardy, John , Ferrucci, Luigi

Mayo Clinic

Stroke | September 23, 2011 | Volume: 42 | Issue: 10 | Pages: 2726-2732

10.1161/strokeaha.111.620484 | PMID 21940970 Get It

Background and Purpose— Ischemic stroke has a strong familial component to risk. The Siblings With Ischemic Stroke Study (SWISS) is a genome-wide, family-based analysis that included use of imputed genotypes. The Siblings With Ischemic Stroke Study was conducted to examine the associations between single-nucleotide polymorphisms (SNPs) and risk of stroke and stroke subtypes within pairs. Methods— The Siblings With Ischemic Stroke Study enrolled 312 probands with ischemic stroke from 70 US and Canadian centers. Affected siblings were ascertained by centers and confirmed by central record review; unaffected siblings were ascertained by telephone contact. Ischemic stroke was subtyped according to Trial of Org 10172 in Acute Stroke Treatment criteria. Genotyping was performed with an Illumina 610 quad array (probands) and an Illumina linkage V array (affected siblings). SNPs were imputed by using 1000 Genomes Project data and MACH software. Family-based association analyses were conducted by using the sibling transmission-disequilibrium test. Results— For all pairs, the correlation of age at stroke within pairs of affected siblings was r =0.83 (95% CI, 0.78–0.86; P <2.2×10 −16 ). The correlation did not differ substantially by subtype. The concordance of stroke subtypes among affected pairs was 33.8% (kappa=0.13; P =5.06×10 −4 ) and did not differ by age at stroke in the proband. Although no SNP achieved genome-wide significance for risk of ischemic stroke, there was clustering of the most associated SNPs on chromosomes 3p and 6p. Conclusions— Stroke subtype and age at stroke in affected sibling pairs exhibit significant clustering. No individual SNP reached genome-wide significance. However, 2 promising candidate loci were, although these risk loci warrant further examination in larger sample collections.